In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary disease (COPD) medications, but you didn’t tell us how to properly use them. I’d ...
In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary ...
BRIDGEWATER, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has ...
Amneal Pharmaceuticals received Food and Drug Administration approval for its albuterol sulfate inhalation aerosol to treat bronchospasm in people with reversible obstructive airway disease. The ...
BRIDGEWATER, N.J. - Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) announced Tuesday that the U.S. Food and Drug Administration has approved its albuterol sulfate inhalation aerosol, a generic equivalent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback